Myasthenia Gravis and Related Disorders
The third edition of this important, gold-standard title outlines a range of significant advances in the study and understanding of myasthenia gravis. The overarching goal of this new edition is identical to the first and second -- to provide the clinician and the scientist with a common resource fo...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Humana,
2018.
|
| Έκδοση: | 3rd ed. 2018. |
| Σειρά: | Current Clinical Neurology,
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Chapter 1. Neuromuscular Junction Physiology and Pathophysiology
- Chapter 2. Acetylcholine Receptor Structure
- Chapter 3. Immunopathogenesis of Myasthenia Gravis
- Chapter 4. Animal Models of Myasthenia Gravis for Preclinical Evaluation
- Chapter 5. Epidemiology and Genetics of Myasthenia Gravis
- Chapter 6. Clinical Presentations of Myasthenia Gravis
- Chapter 7. Ocular Myasthenia
- Chapter 8. Thymoma-associated Myasthenia Gravis
- Chapter 9. Electrodiagnosis of Neuromuscular Junction Disorders
- Chapter 10. Autoantibody Testing in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases
- Chapter 11. Treatment of Myasthenia Gravis
- Chapter 12. Neurocritical Care of Myasthenic Crisis
- Chapter 13. Thymectomy for Non-thymomatous Myasthenia Gravis
- Chapter 14. Lambert-Eaton Syndrome
- Chapter 15 Acquired Neuromyotonia
- Chapter 16. Congenital Myasthenic Syndromes
- Chapter 17. Toxic Neuromuscular Transmission Disorders
- Chapter 18. Predictors of Psychological Health in Myasthenia Gravis
- Chapter 19. Myasthenia Gravis: Classification and Outcome Measurements
- Chapter 20. Emerging Therapeutics for Myasthenia Gravis
- Chapter 21. Clinical Trial Design for Myasthenia Gravis.
